Framework

Clinical Omics

A clinical-first framework for turning molecular measurements into biologically testable questions.

The principle

Start with the patient, not the platform.

Clinical Omics is our framework for designing molecular studies around a precise clinical phenotype. The analytical method is selected only after the biological question, sampling matrix and expected clinical signal are defined.

01

Define

Specify the phenotype, comparison, treatment context and clinically meaningful outcome.

02

Sample

Choose matrices that are biologically proximal to the process under study whenever possible.

03

Measure

Apply targeted or discovery-driven molecular profiling with fit-for-purpose analytical control.

04

Integrate

Connect molecular features to clinical, pharmacological and inflammatory phenotypes.

05

Test

Prioritize mechanisms that can be challenged in experimental systems.

Clinical Omics

Omics are not the endpoint. The endpoint is a biological explanation that survives contact with clinical reality.